Modulation of anticonvulsant effects of cannabinoid compounds by GABA-A receptor agonist in acute pentylenetetrazole model of seizure in rat

Neurochemical Research

Volumn 36, Issue 8, 2011, Pages 1520-1525

  Naderi, Nima ^a   Ahmad Molaei, Leila ^a   Aziz Ahari, Farzad ^a   Motamedi, Fereshteh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cannabinoid; GABA A; Pentylenetetrazole (PTZ); Rat; Seizure

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; [1,1' BIPHENYL] 3 YL CARBAMIC ACID CYCLOHEXYL ESTER; ANTICONVULSIVE AGENT; ARECAIDINE; CANNABINOID RECEPTOR AGONIST; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; PENTETRAZOLE; UNCLASSIFIED DRUG; URB 602;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFECT; GABAERGIC SYSTEM; GRAND MAL SEIZURE; LATENT PERIOD; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; TONIC CLONIC SEIZURE; TREATMENT RESPONSE;

ANIMALS; ANTICONVULSANTS; BENZAMIDES; BENZOXAZINES; BIPHENYL COMPOUNDS; BRAIN; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; CARBAMATES; GABA ANTAGONISTS; GABA-A RECEPTOR AGONISTS; ISONICOTINIC ACIDS; MALE; MORPHOLINES; NAPHTHALENES; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SEIZURES;

RATTUS;

EID: 79961208134     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0479-1     Document Type: Article

References (40)

1. RS Fisher W van Emde Boas W Blume, et al. 2005 Epileptic seizures and epilepsy: definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE) Epilepsia 46 470 472 15816939 10.1111/j.0013-9580.2005.66104.x (Pubitemid 40470667)
2. RE Blair LS Deshpande S Sombati, et al. 2006 Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus J Pharmacol Exp Ther 317 1072 1078 16469864 10.1124/jpet.105.100354 1:CAS:528:DC%2BD28Xlt1eqt7k%3D (Pubitemid 43764110)
3. KW Falenski RE Blair LJ Sim-Selley, et al. 2007 Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy Neuroscience 146 1232 1244 17433556 10.1016/j.neuroscience.2007.01.065 1:CAS:528:DC%2BD2sXlt1Sjtro%3D (Pubitemid 46694119)
4. B Lutz K Monory 2008 Soothing the seizures of children Nat Med 14 721 722 18607372 10.1038/nm0708-721 1:CAS:528:DC%2BD1cXotF2ltbY%3D (Pubitemid 351951513)
5. M Salzet 2000 Invertebrate molecular neuroimmune processes Brain Res Brain Res Rev 34 69 79 11086187 10.1016/S0165-0173(00)00041-2 1:CAS:528:DC%2BD3cXot1yisL8%3D
6. A Ludanyi L Eross S Czirjak, et al. 2008 Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus J Neurosci 28 2976 2990 18354002 10.1523/JNEUROSCI.4465-07.2008 1:CAS:528:DC%2BD1cXjvFCjsL8%3D (Pubitemid 351442292)
7. MA Rogawski 1998 Mechanism-specific pathways for new antiepileptic drug discovery Adv Neurol 76 11 27 9408460 1:CAS:528:DyaK1cXltVyj
8. D Isaev E Isaeva R Khazipov, et al. 2005 Anticonvulsant action of GABA in the high potassium-low magnesium model of ictogenesis in the neonatal rat hippocampus in vivo and in vitro J Neurophysiol 94 2987 2992 16000527 10.1152/jn.00138.2005 1:CAS:528:DC%2BD2MXhtFSkurzJ (Pubitemid 41324713)
9. A Takeda H Itoh M Hirate, et al. 2006 Region-specific loss of zinc in the brain in pentylentetrazole-induced seizures and seizure susceptibility in zinc deficiency Epilepsy Res 70 41 48 16624524 10.1016/j.eplepsyres.2006.03.002 1:CAS:528:DC%2BD28Xms1Gktrg%3D (Pubitemid 43947516)
10. Macdonald RL, Kelly KM (1995) Antiepileptic drug mechanisms of action. Epilepsia 36(Suppl 2):S2-S12
11. JI Lemos RN Takahashi GS Morato 2007 Effects of SR141716 and WIN 55, 212-2 on tolerance to ethanol in rats using the acute and rapid procedures Psychopharmacology (Berl) 194 139 149 10.1007/s00213-007-0804-1 1:CAS:528:DC%2BD2sXhtVKrs7jI (Pubitemid 47457942)
12. E Murillo-Rodriguez E Vazquez D Millan-Aldaco, et al. 2007 Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat Eur J Pharmacol 562 82 91 17336288 10.1016/j.ejphar.2007.01.076 1:CAS:528:DC%2BD2sXjslSktrc%3D (Pubitemid 46466764)
13. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates. Elsevier Academic Press, San Diego
14. J Oommen AC Kraus RS Fisher 2007 Intraventricular administration of gabapentin in the rat increases flurothyl seizure threshold Neurosci Lett 417 308 311 17363166 10.1016/j.neulet.2007.02.051 1:CAS:528:DC%2BD2sXksVyjsbo%3D (Pubitemid 46589784)
15. P Szot D Weinshenker SS White, et al. 1999 Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli J Neurosci 19 10985 10992 10594079 1:CAS:528:DyaK1MXotVyjtro%3D (Pubitemid 30235742)
16. JT Litchfield Jr F Wilcoxon 1949 A simplified method of evaluating dose-effect experiments J Pharmacol Exp Ther 96 99 113 18152921 1:CAS:528:DyaH1MXjvFWmsA%3D%3D
17. MJ Wallace JL Wiley BR Martin, et al. 2001 Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects Eur J Pharmacol 428 51 57 11779037 10.1016/S0014-2999(01)01243-2 1:CAS:528:DC%2BD3MXnsVSluro%3D (Pubitemid 32971757)
18. N Naderi F Aziz Ahari B Shafaghi, et al. 2008 Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice J Neural Transm 115 1501 1511 18575801 10.1007/s00702-008-0076-x 1:CAS:528:DC%2BD1cXhtlSgsb3L
19. M Shen TM Piser VS Seybold, et al. 1996 Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures J Neurosci 16 4322 4334 8699243 1:CAS:528:DyaK28Xktlanu7s%3D (Pubitemid 26243028)
20. MJ Leach CM Marden AA Miller 1986 Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action Epilepsia 27 490 497 3757936 10.1111/j.1528-1157.1986. tb03573.x 1:CAS:528:DyaL28XmtVeitrs%3D (Pubitemid 16026042)
21. BS Meldrum 1994 The role of glutamate in epilepsy and other CNS disorders Neurology 44 S14 S23 7970002 1:STN:280:DyaK2M%2FmtVSgtA%3D%3D
22. TF Freund I Katona D Piomelli 2003 Role of endogenous cannabinoids in synaptic signaling Physiol Rev 83 1017 1066 12843414 1:CAS:528: DC%2BD3sXmtVGmsLk%3D (Pubitemid 36828930)
23. WF White SR Snodgrass 1983 Isoguvacine binding, uptake, and release: relation to the GABA system J Neurochem 40 1701 1708 6854327 10.1111/j.1471-4159.1983.tb08145.x 1:CAS:528:DyaL3sXksVOrsLg%3D (Pubitemid 13106952)
24. U Misgeld M Frotscher 1986 Postsynaptic-GABAergic inhibition of non-pyramidal neurons in the guinea-pig hippocampus Neuroscience 19 193 206 3537840 10.1016/0306-4522(86)90015-1 1:CAS:528:DyaL28Xls1Glu7w%3D (Pubitemid 16053639)
25. Kandel ER, Schwartz JH, Jessell TM (2000) Seizures and epilepsy. In: Principles of neural sciences. Mc Graw-Hill, New York, pp 910-935
26. S Marinelli S Pacioni A Cannich, et al. 2009 Self-modulation of neocortical pyramidal neurons by endocannabinoids Nat Neurosci 12 1488 1491 19915567 10.1038/nn.2430 1:CAS:528:DC%2BD1MXhsVWlsLfL
27. S Marinelli S Pacioni T Bisogno, et al. 2008 The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons J Neurosci 28 13532 13541 19074027 10.1523/JNEUROSCI. 0847-08.2008 1:CAS:528:DC%2BD1cXhsFCqsLfL
28. V Di Marzo M Bifulco L De Petrocellis 2004 The endocannabinoid system and its therapeutic exploitation Nat Rev Drug Discov 3 771 784 15340387 10.1038/nrd1495 1:CAS:528:DC%2BD2cXntFCns7s%3D (Pubitemid 39242829)
29. TP Dinh D Carpenter FM Leslie, et al. 2002 Brain monoglyceride lipase participating in endocannabinoid inactivation Proc Natl Acad Sci USA 99 10819 10824 12136125 10.1073/pnas.152334899 1:CAS:528:DC%2BD38Xmt1ChtLs%3D
30. V Chevaleyre PE Castillo 2003 Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability Neuron 38 461 472 12741992 10.1016/S0896-6273(03)00235-6 1:CAS:528:DC%2BD3sXjvFOrsLo%3D (Pubitemid 36579147)
31. M Egertova BF Cravatt MR Elphick 2003 Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling Neuroscience 119 481 496 12770562 10.1016/S0306- 4522(03)00145-3 1:CAS:528:DC%2BD3sXktFGjsb4%3D (Pubitemid 36588826)
32. A Ameri A Wilhelm T Simmet 1999 Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices Br J Pharmacol 126 1831 1839 10372827 10.1038/sj.bjp.0702478 1:CAS:528:DyaK1MXjtVGqu7o%3D (Pubitemid 29213102)
33. M Maccarrone S Rossi M Bari, et al. 2008 Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum Nat Neurosci 11 152 159 18204441 10.1038/nn2042 1:CAS:528:DC%2BD1cXhtFWrtLo%3D (Pubitemid 351170502)
34. G Marsicano S Goodenough K Monory, et al. 2003 CB1 cannabinoid receptors and on-demand defense against excitotoxicity Science 302 84 88 14526074 10.1126/science.1088208 1:CAS:528:DC%2BD3sXnslSjs78%3D (Pubitemid 37210691)
35. MJ Wallace RE Blair KW Falenski, et al. 2003 The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy J Pharmacol Exp Ther 307 129 137 12954810 10.1124/jpet.103.051920 1:CAS:528:DC%2BD3sXnslGktbw%3D (Pubitemid 37151898)
36. T Sugiura N Yoshinaga S Kondo, et al. 2000 Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain Biochem Biophys Res Commun 271 654 658 10814517 10.1006/bbrc.2000.2686 1:CAS:528:DC%2BD3cXjt1Sjsb4%3D (Pubitemid 30444683)
37. MV Solbrig R Adrian J Baratta, et al. 2005 A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena Exp Neurol 194 355 362 16022863 10.1016/j.expneurol.2005.02.017 1:CAS:528:DC%2BD2MXmt1ejtLo%3D (Pubitemid 40966995)
38. B Moesgaard HH Hansen SL Hansen, et al. 2003 Brain levels of N-acylethanolamine phospholipids in mice during pentylenetetrazol-induced seizure Lipids 38 387 390 12848283 10.1007/s11745-003-1073-1 1:CAS:528:DC%2BD3sXkvFShsrc%3D (Pubitemid 36724295)
39. J Kim BE Alger 2010 Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses Nat Neurosci 13 592 600 20348918 10.1038/nn.2517 1:CAS:528:DC%2BC3cXjvFWjsrc%3D
40. MJ Urbanski FE Kovacs B Szabo 2009 Depolarizing GABAergic synaptic input triggers endocannabinoid-mediated retrograde synaptic signaling Synapse 63 643 652 19347961 10.1002/syn.20641 1:CAS:528:DC%2BD1MXnslGisL0%3D